Elevate Egypt | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,417 results for “Elevate Egypt”

Nigerian Army Pursues Public-Private Partnerships to Modernise Military Healthcare Facilities

Egypt Launches First National Rare Diseases Forum, Unveils Comprehensive Patient Support Strategy

Tralokinumab Demonstrates Efficacy in Reducing Genital Atopic Dermatitis Severity

Egypt and Takeda Pharmaceutical Strengthen Research Partnership to Advance Clinical Trials and Drug Access

Madras High Court Rules Chennai API Maker's Vildagliptin Exports to Egypt Infringed Novartis Patent

Eva Pharma Launches Major Cancer Drug Manufacturing Facility in Egypt to Address Growing Oncology Burden

Gundry MD Launches Elevate NAD+: NMN Supplement with Patent-Pending Beadlet Technology Targets Age-Related NAD+ Decline

ADA 2026 Standards Elevate Cardiorenal Risk Reduction to Co-Primary Goal, Recommend Earlier GLP-1 and SGLT-2 Use

Novartis Wins Egyptian Drug Authority Approval for Kisqali as Adjuvant Therapy in Early Breast Cancer

Egypt's EDA Wins WHO Prequalification for Drug Quality Control Labs, Cementing Maturity Level 3 Status

Page 1 of 29